Crystal structure of 2-(5-phenyl-1-(quinolin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenol, C24H19N3O

被引：1
|
作者：
Zeng, Dai [1 ]
Tan, Kai [1 ]
Fang, Ziyan [1 ]
Xing, Aiping [1 ]
机构：
[1] Henan Univ Chinese Med, Zhengzhou 450046, Peoples R China
来源：
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES | 2023年 / 238卷 / 06期
关键词：
2288022;
D O I：
10.1515/ncrs-2023-0372
中图分类号：
O7 [晶体学];
学科分类号：
0702 ; 070205 ; 0703 ; 080501 ;
摘要：
C24H19N3O, monoclinic, P2(1)/c (no. 14), a = 10.4783(5) angstrom, b = 11.7171(5) angstrom, c = 14.9194(6) angstrom, ss = 93.991(2)degrees, Z = 4, V = 1827.29(14) angstrom(3), R-gt(F) = 0.0521, wR(ref)(F-2) = 0.1508, T = 150(2) K.
引用
收藏
页码：1153 / 1155
页数：3
相关论文
共 50 条
  • [21] N '-Phenyl-N '-[3-(2,4,5-triphenyl-2,5-dihydro-1H-pyrazol-3-yl)quinoxalin-2-yl]benzohydrazide
    Ramli, Youssef
    Karrouchi, Khalid
    Essassi, El Mokhtar
    El Ammari, Lahcen
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O1320 - +
  • [22] Synthesis, Antioxidant and Antidiabetic Activity of 1-[(5-Substituted phenyl)-4,5-dihydro-1H-pyrazol-3-yl]-5-phenyl-1H-tetrazole
    Kaushik, N.
    Kumar, N.
    Kumar, A.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 78 (03) : 351 - 359
  • [23] Synthesis, characterization of some 1-(2-hydroxy-phenyl)-3-(1-phenyl-3-thiophen-2-yl-1H-pyrazol-4-yl)-propenone, 3-chloro-2-(1-phenyl-3-thiophen-2-yl-1H-pyrazol-4-yl)-chromon-4-one and 2-(1′-phenyl-3′-thiophen-2-yl-3,4-dihydro-2H,1H′-[3,4]bipyrazol-5-yl)-phenol
    Halnor, VB
    Joshi, NS
    Karale, BK
    Gill, CH
    HETEROCYCLIC COMMUNICATIONS, 2005, 11 (02) : 167 - 172
  • [24] 6-Chloro-3-[5-(4-fluorophenyl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl]-2-methyl-4-phenylquinoline
    Loh, Wan-Sin
    Fun, Hoong-Kun
    Sarveswari, S.
    Vijayakumar, V.
    Reddy, B. Palakshi
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O304 - U1919
  • [25] Crystal structure of (E)-N-(4-morpholinophenyl)-1-(quinolin-2-yl)methanimine, C20H19N3O
    Jin, Kun-Sheng
    Wu, Wei-Na
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2022, 237 (06): : 1137 - 1138
  • [26] Design, Synthesis, and Cytotoxicity Evaluation of 3-(5-(3-(aryl)-1-phenyl-1H-pyrazol-4-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)pyridine and 5-(3-(aryl)-1-phenyl-1H-pyrazol-4-yl)-3-(pyridin-3-yl)-4,5-dihydropyrazole-1-carbaldehyde Derivatives as Potential Anticancer Agents
    Alam, Raquib
    Alam, Md. Aftab
    Panda, Amulya K.
    Rahisuddin
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2017, 54 (03) : 1812 - 1821
  • [27] Synthesis and Characterization of Novel 2-(1,2,3-Triazol-4-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazoles and 2-(4,5-Dihydro-1H-pyrazol-1-yl)-4-(1H-1,2,3-triazol-4-yl)thiazoles
    Kariuki, Benson M.
    Abdel-Wahab, Bakr F.
    Mohamed, Hanan A.
    Bekheit, Mohamed S.
    El-Hiti, Gamal A.
    MOLECULES, 2022, 27 (24):
  • [28] (Furan-2-yl)(5-hydroxy-3-methyl-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)methanone
    Kargar, Hadi
    Kia, Reza
    Moghadamm, Majid
    Tahir, Muhammad Nawaz
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O367 - U641
  • [29] The crystal structure of 4-((2-(4,5-dihydro-1,5-diphenyl-1H-pyrazol-3-yl)anthracen-10-yl) methyl)morpholine, C34H31N3O
    Zhao Bo
    Cai Lin
    Luo Jiewei
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2019, 234 (03): : 451 - 452
  • [30] 2-[1-(4,6-dimethoxypyrimidin-2-yl)-1H-pyrazol-3-yl]phenol
    Li, Yuan-Xiang
    Wang, Ya-Zhou
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : O873 - O874
12345